Cargando…
Survivin as a Prognostic Factor for Osteosarcoma Patients
Purpose: Survivin is one of the apoptosis inhibitor genes and is rarely expressed in adult tissues. However, survivin expression has been detected in various human cancers and correlations have been recognized between the level of expression of this gene in tumors and prognosis. In this study, we...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Japan Society of Histochemistry and Cytochemistry
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1790971/ https://www.ncbi.nlm.nih.gov/pubmed/17327929 http://dx.doi.org/10.1267/ahc.06005 |
_version_ | 1782132141212041216 |
---|---|
author | Osaka, Eiji Suzuki, Takashi Osaka, Shunzo Yoshida, Yukihiro Sugita, Hideyuki Asami, Satoru Tabata, Keiichi Hemmi, Akihiro Sugitani, Masahiko Nemoto, Norimichi Ryu, Junnosuke |
author_facet | Osaka, Eiji Suzuki, Takashi Osaka, Shunzo Yoshida, Yukihiro Sugita, Hideyuki Asami, Satoru Tabata, Keiichi Hemmi, Akihiro Sugitani, Masahiko Nemoto, Norimichi Ryu, Junnosuke |
author_sort | Osaka, Eiji |
collection | PubMed |
description | Purpose: Survivin is one of the apoptosis inhibitor genes and is rarely expressed in adult tissues. However, survivin expression has been detected in various human cancers and correlations have been recognized between the level of expression of this gene in tumors and prognosis. In this study, we investigated the correlations between survivin mRNA expression in osteosarcoma tissues and clinicopathological parameters. Methods: There were 22 osteosarcoma patients in our hospital with paraffin-embedded tissues which could be extracted from biopsy specimens. We used the RT-PCR method after extracting total RNA and conducted a densitometric analysis to determine the ratio of survivin relative to h-GAPDH as an internal marker. Results: Expression of survivin mRNA was detected in all osteosarcoma samples. Patients with metastasis had high survivin mRNA levels in initial biopsy specimens (p<0.01). Moreover, there was a statistically significant difference in survivin mRNA expression between patients with and without metastasis (p<0.01). Conclusion: We concluded that high levels of survivin mRNA expression suggest poor prognosis for osteosarcoma patients. |
format | Text |
id | pubmed-1790971 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Japan Society of Histochemistry and Cytochemistry |
record_format | MEDLINE/PubMed |
spelling | pubmed-17909712007-02-27 Survivin as a Prognostic Factor for Osteosarcoma Patients Osaka, Eiji Suzuki, Takashi Osaka, Shunzo Yoshida, Yukihiro Sugita, Hideyuki Asami, Satoru Tabata, Keiichi Hemmi, Akihiro Sugitani, Masahiko Nemoto, Norimichi Ryu, Junnosuke Acta Histochem Cytochem Regular Article Purpose: Survivin is one of the apoptosis inhibitor genes and is rarely expressed in adult tissues. However, survivin expression has been detected in various human cancers and correlations have been recognized between the level of expression of this gene in tumors and prognosis. In this study, we investigated the correlations between survivin mRNA expression in osteosarcoma tissues and clinicopathological parameters. Methods: There were 22 osteosarcoma patients in our hospital with paraffin-embedded tissues which could be extracted from biopsy specimens. We used the RT-PCR method after extracting total RNA and conducted a densitometric analysis to determine the ratio of survivin relative to h-GAPDH as an internal marker. Results: Expression of survivin mRNA was detected in all osteosarcoma samples. Patients with metastasis had high survivin mRNA levels in initial biopsy specimens (p<0.01). Moreover, there was a statistically significant difference in survivin mRNA expression between patients with and without metastasis (p<0.01). Conclusion: We concluded that high levels of survivin mRNA expression suggest poor prognosis for osteosarcoma patients. Japan Society of Histochemistry and Cytochemistry 2006-07-01 2006-05-26 /pmc/articles/PMC1790971/ /pubmed/17327929 http://dx.doi.org/10.1267/ahc.06005 Text en Copyright © 2006 AHC This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Regular Article Osaka, Eiji Suzuki, Takashi Osaka, Shunzo Yoshida, Yukihiro Sugita, Hideyuki Asami, Satoru Tabata, Keiichi Hemmi, Akihiro Sugitani, Masahiko Nemoto, Norimichi Ryu, Junnosuke Survivin as a Prognostic Factor for Osteosarcoma Patients |
title | Survivin as a Prognostic Factor for Osteosarcoma Patients |
title_full | Survivin as a Prognostic Factor for Osteosarcoma Patients |
title_fullStr | Survivin as a Prognostic Factor for Osteosarcoma Patients |
title_full_unstemmed | Survivin as a Prognostic Factor for Osteosarcoma Patients |
title_short | Survivin as a Prognostic Factor for Osteosarcoma Patients |
title_sort | survivin as a prognostic factor for osteosarcoma patients |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1790971/ https://www.ncbi.nlm.nih.gov/pubmed/17327929 http://dx.doi.org/10.1267/ahc.06005 |
work_keys_str_mv | AT osakaeiji survivinasaprognosticfactorforosteosarcomapatients AT suzukitakashi survivinasaprognosticfactorforosteosarcomapatients AT osakashunzo survivinasaprognosticfactorforosteosarcomapatients AT yoshidayukihiro survivinasaprognosticfactorforosteosarcomapatients AT sugitahideyuki survivinasaprognosticfactorforosteosarcomapatients AT asamisatoru survivinasaprognosticfactorforosteosarcomapatients AT tabatakeiichi survivinasaprognosticfactorforosteosarcomapatients AT hemmiakihiro survivinasaprognosticfactorforosteosarcomapatients AT sugitanimasahiko survivinasaprognosticfactorforosteosarcomapatients AT nemotonorimichi survivinasaprognosticfactorforosteosarcomapatients AT ryujunnosuke survivinasaprognosticfactorforosteosarcomapatients |